Bernard Coulie, President and CEO at PLIANT THERAPEUTICS, INC. (PLRX), sold 90,000 shares at $32.40 ($3.0M) on 2023-01-25, disclosed to the SEC on 2023-01-25.
Open-market sale of $3.0M PLRX by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $33.71 | 10,150 | $342K | 11.5% |
| 2 | $33.71 | 10,150 | $342K | 11.5% |
| 3 | $34.93 | 4,850 | $169K | 5.7% |
| 4 | $34.93 | 4,850 | $169K | 5.7% |
| 5 | $35.00 | 15,000 | $525K | 17.6% |
| 6 | $30.89 | 15,000 |
| $463K |
| 15.5% |
| 7 | $32.40 | 13,304 | $431K | 14.4% |
| 8 | $32.40 | 13,304 | $431K | 14.4% |
| 9 | $33.29 | 1,696 | $56K | 1.9% |
| 10 | $33.29 | 1,696 | $56K | 1.9% |
| Total | $33.18 avg | 90,000 | $3.0M | 100% |
| Filing → |
| PLRX | SELL | 2024-07-12 | $895K | — | Filing → |
| PLRX | SELL | 2024-01-19 | $886K | — | Filing → |
| PLRX | SELL | 2023-07-19 | $2.5M | — | Filing → |